PUBLISHER: IMARC | PRODUCT CODE: 1379145
PUBLISHER: IMARC | PRODUCT CODE: 1379145
Epigenetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Abstract
The global epigenetics market size reached US$ 2.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.1 Billion by 2028, exhibiting a growth rate (CAGR) of 15.9% during 2022-2028.
Epigenetics refers to the study of heritable changes in the expression of active and inactive genes. The sources of changes can be both external from environmental factors or internal factors, such as age and disease. It is commonly used for the diagnosis of underlying conditions and preventing them from getting transferred to the future generations. It involves the use of various enzymes, instruments, such as sequencers, spectrometers and sonicators, reagents and kits. They are commonly utilized for deoxyribonucleic acid (DNA) and histone methylation, non-coding ribonucleic acid (RNA), acetylation and phosphorylation. As a result, epigenetics is widely used for the diagnosis, monitoring and treatment of oncological, autoimmune, metabolic, cardiovascular and pain disorders.
Epigenetics Market Trends:
The increasing prevalence of cancer and autoimmune deficiency syndrome (AIDS) across the globe is among the key factors driving the market growth. Moreover, the widespread adoption of epigenetic solutions for non-oncological ailments is providing a thrust to the market growth. The sudden outbreak of the coronavirus disease (COVID-19) is also providing growth opportunities to market players. For instance, various research institutes are running advanced epigenetic tests to study the impact of the virus on the human genome and are developing tools for early recognition, risk evaluations and developing personalized treatments. Additionally, the development of DNA and RNA modifying enzymes, such as acetylases, methyltransferases, reverse transcriptase and ligases, and the launch of highly sensitive and selective tests and instruments, are acting as other growth-inducing factors. These innovations facilitate the assessment of locus-specific DNA methylation on a genome. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global epigenetics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, technology and application.
Breakup by Product:
Reagents
Kits
Chip Sequencing Kit
Whole Genomic Amplification Kit
Bisulfite Conversion Kit
RNA Sequencing Kit
Others
Instruments
Enzymes
Services
Breakup by Technology:
DNA Methylation
Histone Methylation
Histone Acetylation
Large Non-Coding RNA
MicroRNA Modification
Chromatin Structures
Breakup by Application:
Oncology
Solid Tumors
Liquid Tumors
Non-Oncology
Inflammatory Diseases
Metabolic Diseases
Infectious Diseases
Cardiovascular Diseases
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Active Motif Inc., Agilent Technologies Inc., Diagenode Diagnostics (Hologic Inc), Illumina Inc., Merck KGaA, PerkinElmer Inc., Roche Holding AG, Thermo Fisher Scientific Inc. and Zymo Research Corporation.
Key Questions Answered in This Report
- 1. How big is the global epigenetics market?
- 2. What is the expected growth rate of the global epigenetics market during 2023-2028?
- 3. What are the key factors driving the global epigenetics market?
- 4. What has been the impact of COVID-19 on the global epigenetics market?
- 5. What is the breakup of the global epigenetics market based on the product?
- 6. What is the breakup of the global epigenetics market based on the technology?
- 7. What is the breakup of the global epigenetics market based on the application?
- 8. What are the key regions in the global epigenetics market?
- 9. Who are the key players/companies in the global epigenetics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Epigenetics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Reagents
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Kits
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Chip Sequencing Kit
- 6.2.2.2 Whole Genomic Amplification Kit
- 6.2.2.3 Bisulfite Conversion Kit
- 6.2.2.4 RNA Sequencing Kit
- 6.2.2.5 Others
- 6.2.3 Market Forecast
- 6.3 Instruments
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Enzymes
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Services
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Technology
- 7.1 DNA Methylation
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Histone Methylation
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Histone Acetylation
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Large Non-Coding RNA
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 MicroRNA Modification
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Chromatin Structures
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by Application
- 8.1 Oncology
- 8.1.1 Market Trends
- 8.1.2 Key Segments
- 8.1.2.1 Solid Tumors
- 8.1.2.2 Liquid Tumors
- 8.1.3 Market Forecast
- 8.2 Non-Oncology
- 8.2.1 Market Trends
- 8.2.2 Key Segments
- 8.2.2.1 Inflammatory Diseases
- 8.2.2.2 Metabolic Diseases
- 8.2.2.3 Infectious Diseases
- 8.2.2.4 Cardiovascular Diseases
- 8.2.2.5 Others
- 8.2.3 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abcam plc
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Active Motif Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Agilent Technologies Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Diagenode Diagnostics (Hologic Inc)
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Illumina Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Merck KGaA
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 PerkinElmer Inc.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Roche Holding AG
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.9 Thermo Fisher Scientific Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Zymo Research Corporation
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.1 Abcam plc
List of Figures
- Figure 1: Global: Epigenetics Market: Major Drivers and Challenges
- Figure 2: Global: Epigenetics Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Epigenetics Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Epigenetics Market: Breakup by Product (in %), 2022
- Figure 5: Global: Epigenetics Market: Breakup by Technology (in %), 2022
- Figure 6: Global: Epigenetics Market: Breakup by Application (in %), 2022
- Figure 7: Global: Epigenetics Market: Breakup by Region (in %), 2022
- Figure 8: Global: Epigenetics (Reagents) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 9: Global: Epigenetics (Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 10: Global: Epigenetics (Kits) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: Epigenetics (Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: Epigenetics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: Epigenetics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: Epigenetics (Enzymes) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: Epigenetics (Enzymes) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: Epigenetics (Services) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: Epigenetics (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: Epigenetics (DNA Methylation) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: Epigenetics (DNA Methylation) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: Global: Epigenetics (Histone Methylation) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: Global: Epigenetics (Histone Methylation) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Global: Epigenetics (Histone Acetylation) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Global: Epigenetics (Histone Acetylation) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: Global: Epigenetics (Large Non-Coding RNA) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: Global: Epigenetics (Large Non-Coding RNA) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: Global: Epigenetics (MicroRNA Modification) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: Global: Epigenetics (MicroRNA Modification) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: Global: Epigenetics (Chromatin Structures) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: Global: Epigenetics (Chromatin Structures) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 30: Global: Epigenetics (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 31: Global: Epigenetics (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 32: Global: Epigenetics (Non-Oncology) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 33: Global: Epigenetics (Non-Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 34: North America: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 35: North America: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 36: United States: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 37: United States: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 38: Canada: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 39: Canada: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 40: Asia-Pacific: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 41: Asia-Pacific: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 42: China: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 43: China: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 44: Japan: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 45: Japan: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 46: India: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 47: India: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 48: South Korea: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 49: South Korea: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 50: Australia: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 51: Australia: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 52: Indonesia: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 53: Indonesia: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 54: Others: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 55: Others: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 56: Europe: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 57: Europe: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 58: Germany: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 59: Germany: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 60: France: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 61: France: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 62: United Kingdom: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 63: United Kingdom: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 64: Italy: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 65: Italy: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 66: Spain: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 67: Spain: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: Russia: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 69: Russia: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 70: Others: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 71: Others: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 72: Latin America: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 73: Latin America: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 74: Brazil: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 75: Brazil: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 76: Mexico: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 77: Mexico: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 78: Others: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 79: Others: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 80: Middle East and Africa: Epigenetics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 81: Middle East and Africa: Epigenetics Market: Breakup by Country (in %), 2022
- Figure 82: Middle East and Africa: Epigenetics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 83: Global: Epigenetics Industry: SWOT Analysis
- Figure 84: Global: Epigenetics Industry: Value Chain Analysis
- Figure 85: Global: Epigenetics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Epigenetics Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Epigenetics Market Forecast: Breakup by Product (in Million US$), 2023-2028
- Table 3: Global: Epigenetics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
- Table 4: Global: Epigenetics Market Forecast: Breakup by Application (in Million US$), 2023-2028
- Table 5: Global: Epigenetics Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 6: Global: Epigenetics Market: Competitive Structure
- Table 7: Global: Epigenetics Market: Key Players
